Wilhelm Ridderstrale
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial.
Journal: Journal of the American Heart Association
Published: July 29, 2025
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.
Journal: NEJM evidence
Published: February 06, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.
Journal: Journal of the American College of Cardiology
Published: December 21, 2023
Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence.
Journal: Contemporary clinical trials communications
Published: December 08, 2023
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
Journal: American heart journal
Published: July 05, 2023
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: October 08, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
Journal: Journal of the American College of Cardiology
Published: July 10, 2020
Safety and Cumulative Incidence of Major Cardiovascular Events with Ticagrelor in Taiwanese Patients with Non-ST-Segment Elevation Myocardial Infarction: A 12-Month, Prospective, Phase IV, Multicenter, Single-Arm Study.
Journal: Acta Cardiologica Sinica
Published: May 20, 2020
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Journal: The New England journal of medicine
Published: September 03, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Journal: Lancet (London, England)
Published: July 03, 2019
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
Journal: Clinical cardiology
Published: February 12, 2019
Last Updated: 09/26/2026